We are live on
!
Find out more
FAF
Fjarde Ap-fonden Portfolio holdings
AUM
$20.9B
1-Year Est. Return
36.93%
This Fund
S&P 500
This Quarter
Est. Return
+2.06%
1 Year Est. Return
+36.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.35B
AUM Growth
-$265M
(-5.7%)
Cap. Flow
-$308M
Cap. Flow
% of AUM
-7.08%
Top 10 Holdings %
Top 10 Hldgs %
16.54%
Holding
629
New
5
Increased
18
Reduced
506
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$6.19M |
| 2 |
Medtronic
MDT
|
+$6.17M |
| 3 |
Qorvo
QRVO
|
+$3.05M |
| 4 |
Alkermes
ALKS
|
+$3M |
| 5 |
Comcast
CMCSA
|
+$2.55M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$15M |
| 2 |
Apple
AAPL
|
+$12.4M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$11M |
| 4 |
ExxonMobil
XOM
|
+$5.57M |
| 5 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$4.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.89% |
| 2 | Technology | 15.07% |
| 3 | Financials | 14.56% |
| 4 | Consumer Discretionary | 9.39% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Everest Group
EG
$14.2B
| $2.39M | 0.06% |
13,739
| – | – |
|
|
ANSS
427
DELISTED
Ansys
ANSS
| $2.38M | 0.05% |
27,001
-989
| -4% | -$83.6K |
|
|
COL
428
DELISTED
Rockwell Collins
COL
| $2.38M | 0.05% |
24,640
-2,193
| -8% | -$196K |
|
429
Willis Towers Watson
WTW
$31.5B
| $2.37M | 0.05% |
18,468
| – | – |
|
|
LLTC
430
DELISTED
Linear Technology Corp
LLTC
| $2.37M | 0.05% |
50,684
-7,162
| -12% | -$335K |
|
431
Vulcan Materials
VMC
$36.9B
| $2.36M | 0.05% |
28,010
-2,615
| -9% | -$202K |
|
432
Equifax
EFX
$20.8B
| $2.36M | 0.05% |
25,366
-2,845
| -10% | -$252K |
|
433
Oneok
OKE
$55.2B
| $2.36M | 0.05% |
48,858
| – | – |
|
|
CA
434
DELISTED
CA, Inc.
CA
| $2.36M | 0.05% |
72,263
-6,729
| -9% | -$213K |
|
435
Molson Coors Class B
TAP
$7.93B
| $2.35M | 0.05% |
31,593
-3,898
| -11% | -$294K |
|
|
XEC
436
DELISTED
CIMAREX ENERGY CO
XEC
| $2.35M | 0.05% |
20,401
| – | – |
|
|
GAP
437
The Gap Inc
GAP
$7.42B
| $2.33M | 0.05% |
53,753
| – | – |
|
|
SPLS
438
DELISTED
Staples Inc
SPLS
| $2.33M | 0.05% |
141,942
-9,136
| -6% | -$153K |
|
439
C.H. Robinson
CHRW
$18.1B
| $2.33M | 0.05% |
31,797
-2,773
| -8% | -$203K |
|
440
TripAdvisor
TRIP
$1.67B
| $2.32M | 0.05% |
27,921
-1,216
| -4% | -$95.6K |
|
441
Eastman Chemical
EMN
$8.45B
| $2.32M | 0.05% |
33,515
-1,362
| -4% | -$98.3K |
|
442
Microchip Technology
MCHP
$43.8B
| $2.3M | 0.05% |
93,992
-6,212
| -6% | -$150K |
|
443
Crown Holdings
CCK
$13.2B
| $2.3M | 0.05% |
42,523
| – | – |
|
444
Expedia Group
EXPE
$37.5B
| $2.29M | 0.05% |
24,377
| – | – |
|
|
CPN
445
DELISTED
Calpine Corporation
CPN
| $2.29M | 0.05% |
100,357
-2,980
| -3% | -$64.3K |
|
446
Wynn Resorts
WYNN
$10.1B
| $2.29M | 0.05% |
18,193
-1,168
| -6% | -$167K |
|
447
WEC Energy
WEC
$35.6B
| $2.27M | 0.05% |
45,901
-7,837
| -15% | -$410K |
|
|
IHS
448
DELISTED
IHS INC CL-A COM STK
IHS
| $2.25M | 0.05% |
19,795
-1,895
| -9% | -$219K |
|
449
Darden Restaurants
DRI
$23.4B
| $2.25M | 0.05% |
36,214
| – | – |
|
450
T-Mobile US
TMUS
$190B
| $2.24M | 0.05% |
70,776
-8,126
| -10% | -$253K |
|
Similar funds
MMH
VARA
SC
CB
MIC
GT
Fjarde Ap-fonden's Q1 2015 Portfolio in Review
As of Q1 2015, Fjarde Ap-fonden held 629 positions worth $4.35B, down 5.7% from $4.62B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Fjarde Ap-fonden withdrew a net $308M in Q1 2015, closing 10 positions and reducing 506 holdings. Its most notable exit was Allergan Inc, an estimated $15M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, Fjarde Ap-fonden opened a new position in Qorvo worth $3.42M.
- Fjarde Ap-fonden's largest Q1 2015 buy was Qorvo: 42,872 shares worth $3.42M.
- Fjarde Ap-fonden added most to Allergan plc in Q1 2015, an estimated $6.19M increase.
- Fjarde Ap-fonden's biggest Q1 2015 reduction was Apple, cutting an estimated $12.4M.
- Fjarde Ap-fonden fully exited Allergan Inc in Q1 2015, selling an estimated $15M.
- Fjarde Ap-fonden's ten largest holdings make up 17% of its $4.35B portfolio in Q1 2015.
- Fjarde Ap-fonden opened 5 new positions and closed 10 in Q1 2015.
- Fjarde Ap-fonden's portfolio value fell 5.7% quarter-over-quarter to $4.35B.
Based on Fjarde Ap-fonden's 13F filing for Q1 2015, filed 13 Apr 2015.